Skip to main content

Table 3 Fatty acid profile (mol %) of serum total lipid in subjects on the three experimental diets (n = 21)

From: An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans

  AAD LA Diet ALA Diet
SFA 34.7 ± 0.6 33.0 ± 0.5* 33.5 ± 0.5
MUFA 20.0 ± 0.6 17.0 ± 0.6 17.9 ± 0.6
PUFA 45.5 ± 0.7 50.1 ± 0.7 48.7 ± 0.7
n-6 PUFA 42.0 ± 0.6 44.9 ± 0.6 42.1 ± 0.6§
LA 33.3 ± 0.5 37.1 ± 0.5 34.6 ± 0.5
AA 8.2 ± 0.4 7.5 ± 0.4 7.3 ± 0.4
n-3 PUFA 3.4 ± 0.3 5.2 ± 0.3 6.6 ± 0.3‡§
ALA 0.8 ± 0.2 2.1 ± 0.2 3.1 ± 0.2‡•
EPA 0.5 ± 0.1 0.7 ± 0.1 1.2 ± 0.1‡¶
DPA 0.6 ± 0.04 0.7 ± 0.04 0.7 ± 0.04‡¶
DHA 1.6 ± 0.1 1.7 ± 0.1 1.5 ± 0.1
SFA/UNSAT 0.53 ± 0.01 0.49 ± 0.01 0.50 ± 0.01*
LA/ALA 49.6 ± 2.3 19.3 ± 2.3 12.4 ± 2.3‡¶
n-6/n-3 12.7 ± 0.5 9.0 ± 0.5 6.8 ± 0.5‡§
  1. SFA: Saturated fatty acids; MUFA: Monounsaturated fatty acids; PUFA: Polyunsaturated fatty acids; n-6: omega-6; LA: Linoleic acid; AA: Arachidonic acid; n-3: omega-3; ALA: α-linolenic acid; EPA: Eicosapentaenoic acid; DPA: Docosapentaenoic acid; DHA: Docosahexaenoic acid; UNSAT: total unsaturated fatty acids
  2. *: P < 0.05, †: P < 0.01,‡: P < 0.001, compared with AAD
  3. P < 0.05,•: P < 0.01,§ P < 0.001 compared with LA Diet